EPISODE · Nov 10, 2025 · 6 MIN
#375 - 🟠 CHNC 2025 COVERAGE - New changes in ECMO anticoagulation
from The Incubator · host Ben Courchia & Daphna Yasova Barbeau
Send us Fan MailIn this CHNC 2025 episode, The Incubator speaks with Dr. Sandy Johng (Seattle Children’s) and Dr. Kelsey Montgomery (Riley Children’s Hospital) about the collaborative work of the CDH Focus Group within the consortium. They discuss a national effort to evaluate bivalirudin versus heparin for ECMO anticoagulation in infants with congenital diaphragmatic hernia—a shift driven by promising anecdotal evidence but lacking robust data. Through shared cases, systematic review, and consensus guideline development, the group aims to unify practice and elevate research quality. The conversation highlights how real-time collaboration accelerates learning, improves care consistency, and fosters innovation across Level IV NICUs nationwide.Support the showAs always, feel free to send us questions, comments, or suggestions to our email: [email protected]. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below.Enjoy!
Embed this episode
What this episode covers
Send us Fan Mail In this CHNC 2025 episode, The Incubator speaks with Dr. Sandy Johng (Seattle Children’s) and Dr. Kelsey Montgomery (Riley Children’s Hospital) about the collaborative work of the CDH Focus Group within the consortium. They discuss a national effort to evaluate bivalirudin versus heparin for ECMO anticoagulation in infants with congenital diaphragmatic hernia—a shift driven by promising anecdotal evidence but lacking robust data. Through shared cases, systematic review, and c...
NOW PLAYING
#375 - 🟠 CHNC 2025 COVERAGE - New changes in ECMO anticoagulation
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.